Insights

Early cancer detection Target healthcare providers and payers with the OneTest platform for early cancer detection and chronic disease risk reduction, emphasizing AI-powered accuracy, accessibility via at-home collection, and CAP/CLIA-compliant lab capabilities to support proactive preventive care strategies.

Longevity Market Position OneTest for Longevity as a differentiator to wellness clinics and aging-focused services, offering biological age tracking, inflammation management, and lifestyle guidance to tap into the growing health optimization and preventive medicine segments.

SMB-to-Regional Growth Leverage the company’s compact team and scalable tech stack to pursue partnerships with mid-market clinics, independent labs, and regional health systems seeking cost-effective AI-enabled diagnostics and streamlined lab workflows.

Investor Relations Momentum Use the newly launched Investor Relations section to engage potential strategic investors and healthcare-focused funds, highlighting revenue potential, product roadmap, and clinical validation to support fundraising and channel expansion.

Data-Driven Partnerships Emphasize opportunities to collaborate with data partners and researchers to expand real-world evidence, improve model performance, and broaden the applicability of OneTest across cancer and chronic disease risk stratification.

Similar companies to 20/20 Biolabs, Inc.

20/20 Biolabs, Inc. Tech Stack

20/20 Biolabs, Inc. uses 8 technology products and services including html5media, WordPress, Microsoft 365, and more. Explore 20/20 Biolabs, Inc.'s tech stack below.

  • html5media
    Audio, Video, Graphics
  • Content Management System
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Elementor
    Page Builders
  • reCAPTCHA
    Security
  • Apache
    Web Servers

20/20 Biolabs, Inc.'s Email Address Formats

20/20 Biolabs, Inc. uses at least 4 email formats:
20/20 Biolabs, Inc. Email FormatsExamplePercentage
FLast@2020gene.comJDoe@2020gene.com
82%
FirstL@2020gene.comJohnD@2020gene.com
10%
Last@2020gene.comDoe@2020gene.com
8%
FLast@2020biolabs.comJDoe@2020biolabs.com
100%

Frequently Asked Questions

What is 20/20 Biolabs, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact 20/20 Biolabs, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 20/20 Biolabs, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc.'s official website is 2020biolabs.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does 20/20 Biolabs, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, 20/20 Biolabs, Inc.'s annual revenue is estimated to be $1M - $10M.

What is 20/20 Biolabs, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 20/20 Biolabs, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, 20/20 Biolabs, Inc. has approximately 29 employees across 3 continents, including North America, Asia and Europe. Key team members include Chairman: J. C., Senior Vice President And Chief Operating Officer: V. K. and Sales Manager: D. L. Explore 20/20 Biolabs, Inc.'s employee directory with LeadIQ.

What industry does 20/20 Biolabs, Inc. belong to?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc. operates in the Biotechnology Research industry.

What technology does 20/20 Biolabs, Inc. use?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc.'s tech stack includes html5media, WordPress, Microsoft 365, jQuery, jQuery Migrate, Elementor, reCAPTCHA and Apache.

What is 20/20 Biolabs, Inc.'s email format?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc.'s email format typically follows the pattern of FLast@2020gene.com. Find more 20/20 Biolabs, Inc. email formats with LeadIQ.

How much funding has 20/20 Biolabs, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, 20/20 Biolabs, Inc. has raised $749K in funding. The last funding round occurred on Dec 13, 2025 for $1.4M.

When was 20/20 Biolabs, Inc. founded?

Minus sign iconPlus sign icon
20/20 Biolabs, Inc. was founded in 2000.
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc.

Biotechnology ResearchMaryland, United States11-50 Employees

20/20 BioLabs, Inc. operates a CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland, conducting AI-powered, laboratory-based blood tests focused on the early detection and prevention of cancers and chronic diseases. Through its OneTest brand, including OneTest for Cancer and OneTest for Longevity, the company offers tests designed to deliver affordable, accurate, and actionable health insights derived from machine learning and real-world data. These tests enable individuals to track biological age, monitor systemic inflammation, and follow evidence-based dietary and lifestyle guidance to lower disease risk, with at-home, needle-free sample collection and explainable AI supporting the results.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
11-50

Section iconFunding & Financials

  • $749K

    20/20 Biolabs, Inc. has raised a total of $749K of funding over 1 rounds. Their latest funding round was raised on Dec 13, 2025 in the amount of $1.4M as an Equity Crowdfunding.

  • $1M - $10M

    20/20 Biolabs, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.